Back to ABT
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA → ABT
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ABT Position History
Abbott Laboratories • Healthcare
Quarters held
16
Latest value
$544K
Q3 2026
Peak value
$176.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $176.9M |
| Q4 2025 | $56K |
| Q4 2025 | $232K |
| Q4 2025 | $1.1M |
| Q1 2026 | $160.8M |
| Q1 2026 | $52K |
| Q1 2026 | $215K |
| Q1 2026 | $856K |
| Q2 2026 | $141.3M |
| Q2 2026 | $47K |
| Q2 2026 | $194K |
| Q2 2026 | $542K |
| Q3 2026 | $150.5M |
| Q3 2026 | $51K |
| Q3 2026 | $211K |
| Q3 2026 | $544K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $544K | 5.5K | — | — |
| Q3 2026 | $211K | 2.1K | — | — |
| Q3 2026 | $51K | 519 | — | — |
| Q3 2026 | $150.5M | 1.52M | — | — |
| Q2 2026 | $542K | 6.0K | — | — |
| Q2 2026 | $194K | 2.1K | — | — |
| Q2 2026 | $47K | 519 | — | — |
| Q2 2026 | $141.3M | 1.56M | — | — |
| Q1 2026 | $856K | 8.5K | — | — |
| Q1 2026 | $215K | 2.1K | — | — |
| Q1 2026 | $52K | 519 | — | — |
| Q1 2026 | $160.8M | 1.60M | — | — |
| Q4 2025 | $1.1M | 9.9K | — | — |
| Q4 2025 | $232K | 2.1K | — | — |
| Q4 2025 | $56K | 519 | — | — |
| Q4 2025 | $176.9M | 1.63M | — | — |
Other funds holding ABT
$22.4B
$21.5B
$19.8B
$10.7B
$10.5B
$10.3B